Nutex Health, Inc.

NASDAQ:NUTX

Medical - Healthcare Information Services

Healthcare
$172.74 +1.94%

+$2.84 today

Market cap
$1.19B
Beta
2.06
P/E (TTM)
10.4
EPS (TTM)
$14.38
52W Low $77.21High $193.07

Volume 0.16M

Average 0.17M

NUTX EBITDA Margin

EBITDA as a percentage of revenue.

Nutex Health, Inc.NASDAQ: NUTX

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to 40.1%

EBITDA Margin was 40.1% in Q1 FY2026, up 5.1 pp from a year earlier. On a trailing-twelve-month basis it was 33.2%, down 1.1 pp year over year. Over 3 fiscal years it widened by 212.5 pp.

Context

  • EBITDA Margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 4 analysts of 35.6% for the fiscal year ending Dec 2026, up from 32.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
40.1%+16.3 pp QoQ
Last fiscal yearDec 2025
32.9%+1.9 pp YoY
LTMMar 2026
33.2%-1.1 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+5.1 pp+13.7 pp+8.5 pp
1 year+1.9 pp+2.8 pp+0.9 pp
3 years+212.5 pp-1.6 pp-214.2 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
32.9%
Year-over-year change
+1.9pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How NUTX compares with its peers on the latest reported figures

  • NUTX's LTM Mar 2026 EBITDA Margin of 33.2% is the highest of the 11 companies compared; the peer median is 17.7%.
  • Its year-over-year change of -1.1 pp is the 8th highest of 11, against a peer median of +0.9 pp.
  • Over three fiscal years its change of +212.5 pp compares with a peer median of -0.6 pp.
NUTX Competitors Peer median
EBITDA Margin for NUTX and competitors
Company Period LTM level YoY 3-year change
NUTXNutex Health, Inc.LTM Mar 202633.2% -1.1 pp+212.5 pp
EHCEncompass Health CorporationLTM Jun 202624.2% +1.1 pp+3.6 pp
THCTenet Healthcare CorporationLTM Jun 202623.2% +0.9 pp+5.0 pp
CYHCommunity Health Systems, Inc.LTM Mar 202623.1% +13.2 pp+6.6 pp
CONConcentra Group Holdings Parent, Inc.LTM Sep 202620.5% +1.3 pp-0.2 pp
SGRYSurgery Partners, Inc.LTM Sep 202619.9% -5.0 pp-1.0 pp
UHSUniversal Health Services, Inc.LTM Jun 202615.6% +0.8 pp+4.0 pp
ARDTArdent Health Partners, LLCLTM Mar 20267.9% -1.5 pp-2.5 pp
ASTHAstrana Health, Inc.LTM Mar 20264.6% -1.1 pp-5.5 pp
INNVInnovAge Holding Corp.LTM Mar 20260.5% +1.0 pp-0.9 pp
AGLAgilon Health, Inc.LTM Mar 2026-5.9% -2.2 pp-3.2 pp
Peer median (excluding NUTX) 17.7%+0.9 pp-0.6 pp

Competitors are the stored peer set for NUTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue331.53M219.29M247.65M479.95M875.26M
Cost of Revenue152.25M203.87M212.87M283.69M430.98M
Gross Profit179.28M15.42M34.77M196.26M444.28M
Gross Margin54.1%7.0%14.0%40.9%50.8%
Research & Development285.88K0000
Selling, General & Admin5.46M20M36.07M58.56M168.66M
Operating Expenses9.02M422.02M66.55M65.64M168.66M
Depreciation & Amortization7.76M13.13M17.59M18.97M20.53M
EBITDA183.45M(394.03M)(14.58M)148.65M287.54M
EBITDA Margin55.3%-179.7%-5.9%31.0%32.9%
Operating Income170.26M(406.6M)(31.77M)130.62M275.63M
Operating Margin51.4%-185.4%-12.8%27.2%31.5%
Interest Income00000
Interest Expense6.2M12.49M16.32M19.93M22.23M
Other Income / Expenses(773.88K)(13.05M)(16.72M)(20.87M)(30.84M)
Income Before Tax169.49M(419.65M)(48.49M)109.75M244.78M
Pre-Tax Margin51.1%-191.4%-19.6%22.9%28.0%
Income Tax Expense965.73K13.09M(5.07M)14.48M64.42M
Net Income132.59M(424.78M)(45.79M)52.18M70.79M
Net Margin40.0%-193.7%-18.5%10.9%8.1%
EPS (Basic)33.55(100.50)(10.39)10.2311.13
EPS (Diluted)33.55(100.36)(10.39)9.7110.48
Weighted Avg Shares4.02M4.23M4.41M5.1M6.36M
Weighted Avg Shares (Diluted)3.95M4.23M4.41M5.1M6.76M

Nutex Health, Inc.

NASDAQ:NUTX

Intrinsic Alpha fair value

Locked

Current Price

$172.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.